C

우리바이오

082850KOSDAQ기타 식품 제조업

42.5 / 100

Reference Date: 2026-04-13

Financial Score11.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Rose 6.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Ourbio operates five business segments, including health functional foods, FPCB and electronic components, LED modules, real estate, and nanofiber fabrics. It is actively expanding its health functional food market through brands like 'Solutio' and 'Harutin,' while the FPCB segment benefits from growing demand in smart devices and automotive industries. The company is also expanding into bio-related fields, such as medical cannabis research.

Number of Employees

95people

Average Salary

45.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 13.534.0Point
PBR
0.36Industry Average 0.645.5Point

Lower than industry avg (good)

ROE
-3.84Industry Average 2.720.0Point

Well below industry avg

Debt Ratio
18.87Industry Average 11.910.5Point

1.6x industry avg (risky)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼8.9% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼67.6% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 2.4% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (39%)

Current 1,950Won52-week high 2,57052-week low 1,542
1-month return4.0Point

1m +6.85% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
  • Neutral주식등의대량보유상황보고서(일반)2026-04-07
  • Neutral정기주주총회결과2026-03-31
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
  • Neutral[기재정정]주주총회소집공고2026-03-24